Uveitis clinical trials at UCSF

2 in progress, 1 open to eligible people

Uveitis occurs when the middle part of the eye gets inflamed. UCSF is running trials using sequencing technology to investigate the causes of eye inflammation. Research teams are also comparing new treatments to standard approaches employed in current care.

Showing trials for

  • Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing

    open to eligible people ages 18 years and up

    This is a multi-center randomized controlled evaluator-masked trial designed to compare metagenomic deep sequencing (MDS) versus standard of care testing for improvement of outcomes for intraocular infections. Patients with presumed intraocular infections who meet the eligibility criteria will be randomized to receive MDS testing results or not to receive MDS testing results. All patients will receive standard-of-care testing to guide management. Enrolled patients will be followed at week 2, week 3-6 (randomization visit), and at 4 weeks after the randomization visit. The proportions of patients who received the appropriate therapy and the proportions of patients with improved outcome will be compared between arms. Patient quality of life, MDS performance, and the provider certainly of belief will be collected.

    San Francisco, California

  • Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases

    Sorry, in progress, not accepting new patients

    The proposed study is a block-randomized, controlled trial to evaluate the effects of a digital meditation and mindfulness practice on mental health in patients with non-infectious uveitis.

    San Francisco, California

Our lead scientists for Uveitis research studies include .

Last updated: